Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-041820
Filing Date
2017-06-26
Accepted
2017-06-26 15:47:20
Documents
1
Period of Report
2017-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4167
  Complete submission text file 0001209191-17-041820.txt   5565
Mailing Address LICHISTRASSE 35 WSJ-200.108 CH 4002 POSTFACH BASEL V8 00000
Business Address
VASELLA DANIEL (Reporting) CIK: 0001189152 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37347 | Film No.: 17929859

Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Issuer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations